Form 8-K - Current report:
SEC Accession No. 0001171843-17-001289
Filing Date
2017-03-03
Accepted
2017-03-03 15:38:07
Documents
6
Period of Report
2017-03-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_030317.htm 8-K 17183
2 EXHIBIT 5.1 exh_51.htm EX-5.1 18366
3 EXHIBIT 10.1 exh_101.htm EX-10.1 45845
4 EXHIBIT 99.1 exh_991.htm EX-99.1 5288
5 GRAPHIC se_logo.jpg GRAPHIC 16327
6 GRAPHIC se_logosm.jpg GRAPHIC 4398
  Complete submission text file 0001171843-17-001289.txt   116653
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37347 | Film No.: 17663276
SIC: 2834 Pharmaceutical Preparations